News Update from HCV Advocate

[Guest guest]

HCV ADVOCATE WEEKLY NEWS REVIEW:> A Review of HCV, HBV and HIV/HCV Coinfection

Related News and Highlights> > Week Ending: January 19th, 2008> > Alan

Franciscus> Editor-in-Chief> > To download pdf version click >

<http://www.hcvadvocate.org/news/NewsUpdates_pdf/News_Review_2008/NewsRev-240.pd\

f>here> > This Issue:> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Healthcare_Help_\

for>Healthcare > Help for the Burmese> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Britain's_transp\

lant_crisis:>Britain's > transplant crisis: Poor lifestyle fuels big rise in

waiting lists> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_SF_med_center>SF

> med center to use gene therapy> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Studies_from_Uni\

versity>Studies > from University of California in the area of cancer vaccines

published> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Court_Declines_E\

xperimental>Court > Declines Experimental Drugs Case> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Schering-Plough_\

Reports_Top-Line>Schering-Plough > Reports Top-Line Results of the Ideal Study>

* >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Roche_Responds_t\

o>Roche > Responds to Announcement of " IDEAL " Hepatitis C Trial Results> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Drug_Approved._I\

s>Drug > Approved. Is Disease Real?> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Study_Probes_Why\

>Study > Probes Why U.S. Blacks Wary of Medical Trials> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Three_Rivers_Pha\

rmaceuticals®,>Three > Rivers Pharmaceuticals®, LLC Acquires Hepatitis C

Drug Infergen® > from Valeant Pharmaceuticals> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_New_York_outpati\

ent>New > York outpatient oversight among toughest> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Proteomic_profil\

ing_shown>Proteomic > profiling shown more accurate than traditional biomarkers

in > identifying liver cancer> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Basic_accord_end\

s>Basic > accord ends hepatitis C legal fights> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Lessening_the_Bu\

rden>Lessening > the Burden of Hepatitis B Virus Infection and Liver Cancer

Among > Asian and Pacific Islander Americans> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_GB_Virus_C>GB >

Virus C May Reduce Severity of HCV-Related Liver Disease in HIV Patients> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Ribosomal_S-6_Ki\

nase>Ribosomal > S-6 Kinase Mediates Development of Liver Fibrosis> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Living_Donor_Liv\

er>Living > Donor Liver Transplant Yields Better Survival Than Deceased Donor> *

>

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Percutaneous_Rad\

iofrequency_Ablatio>Percutaneous > Radiofrequency Ablation Effective for Small

Liver Tumors> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Acute_inflammato\

ry_demyelinating>Acute > inflammatory demyelinating polyneuropathy associated

with pegylated > interferon alpha 2a therapy for chronic hepatitis C virus

infection> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Dept._of_Health:\

>Dept. > of Health: Manhasset doc reused syringes> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Hepatitis_C_Case\

s>Hepatitis > C Cases Alarm Bosnian Doctors> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Outpatient_clini\

c_had>Outpatient > clinic had its own hepatitis outbreak> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Attention:_Extra\

-hepatic_manifestat>Attention: > Extra-hepatic manifestation of hepatitis C

virus infection> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Vertex_Shares_Ri\

se>Vertex > Shares Rise After Upgrade> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_What_is_the>What

> is the more suitable for early detection of low abundant >

lamivudine-resistant mutants?> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Liver-gender_dis\

ruption_makes>Liver-gender > disruption makes men more vulnerable to liver

cancer> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Number_of_Hepati\

tis>Number > of Hepatitis Cases Climbs in Southern West Virginia> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Innogenetics_say\

s_US>Innogenetics > says US court confirms Abbott infringed Hepatitis C virus

patent> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Treatment_of_Hep\

atitis>Treatment > of Hepatitis C Reduces Incidence of Non-Hodgkin's Lymphoma> *

>

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_The_Good_Times>T\

he > Good Times Roll for Pharmasset> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Philippines_orde\

rs_Novartis>Philippines > orders Novartis to pull anti-arthritis drug> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Sen._Brown_Reque\

sts>Sen. > Brown Requests Probe of FDA's Fast-Track Drug Approvals> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Hemophiliac_Soci\

ety_says>Hemophiliac > Society says tainted blood victims will be inflamed by

dropped charges> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Plan_in_works>Pl\

an > in works to cover uninsured> > For the Team at HCSP> > CD Mazoff, PhD>

Managing Editor, Webmaster> HCV Advocate> www.hcvadvocate.org> HBV Advocate>

www.hbvadvocate.org

_________________________________________________________________

Connect and share in new ways with Windows Live.

http://www.windowslive.com/share.html?ocid=TXT_TAGHM_Wave2_sharelife_012008

[Guest guest]

HCV ADVOCATE WEEKLY NEWS REVIEW:> A Review of HCV, HBV and HIV/HCV Coinfection

Related News and Highlights> > Week Ending: January 19th, 2008> > Alan

Franciscus> Editor-in-Chief> > To download pdf version click >

<http://www.hcvadvocate.org/news/NewsUpdates_pdf/News_Review_2008/NewsRev-240.pd\

f>here> > This Issue:> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Healthcare_Help_\

for>Healthcare > Help for the Burmese> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Britain's_transp\

lant_crisis:>Britain's > transplant crisis: Poor lifestyle fuels big rise in

waiting lists> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_SF_med_center>SF

> med center to use gene therapy> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Studies_from_Uni\

versity>Studies > from University of California in the area of cancer vaccines

published> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Court_Declines_E\

xperimental>Court > Declines Experimental Drugs Case> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Schering-Plough_\

Reports_Top-Line>Schering-Plough > Reports Top-Line Results of the Ideal Study>

* >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Roche_Responds_t\

o>Roche > Responds to Announcement of " IDEAL " Hepatitis C Trial Results> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Drug_Approved._I\

s>Drug > Approved. Is Disease Real?> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Study_Probes_Why\

>Study > Probes Why U.S. Blacks Wary of Medical Trials> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Three_Rivers_Pha\

rmaceuticals®,>Three > Rivers Pharmaceuticals®, LLC Acquires Hepatitis C

Drug Infergen® > from Valeant Pharmaceuticals> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_New_York_outpati\

ent>New > York outpatient oversight among toughest> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Proteomic_profil\

ing_shown>Proteomic > profiling shown more accurate than traditional biomarkers

in > identifying liver cancer> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Basic_accord_end\

s>Basic > accord ends hepatitis C legal fights> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Lessening_the_Bu\

rden>Lessening > the Burden of Hepatitis B Virus Infection and Liver Cancer

Among > Asian and Pacific Islander Americans> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_GB_Virus_C>GB >

Virus C May Reduce Severity of HCV-Related Liver Disease in HIV Patients> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Ribosomal_S-6_Ki\

nase>Ribosomal > S-6 Kinase Mediates Development of Liver Fibrosis> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Living_Donor_Liv\

er>Living > Donor Liver Transplant Yields Better Survival Than Deceased Donor> *

>

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Percutaneous_Rad\

iofrequency_Ablatio>Percutaneous > Radiofrequency Ablation Effective for Small

Liver Tumors> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Acute_inflammato\

ry_demyelinating>Acute > inflammatory demyelinating polyneuropathy associated

with pegylated > interferon alpha 2a therapy for chronic hepatitis C virus

infection> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Dept._of_Health:\

>Dept. > of Health: Manhasset doc reused syringes> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Hepatitis_C_Case\

s>Hepatitis > C Cases Alarm Bosnian Doctors> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Outpatient_clini\

c_had>Outpatient > clinic had its own hepatitis outbreak> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Attention:_Extra\

-hepatic_manifestat>Attention: > Extra-hepatic manifestation of hepatitis C

virus infection> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Vertex_Shares_Ri\

se>Vertex > Shares Rise After Upgrade> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_What_is_the>What

> is the more suitable for early detection of low abundant >

lamivudine-resistant mutants?> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Liver-gender_dis\

ruption_makes>Liver-gender > disruption makes men more vulnerable to liver

cancer> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Number_of_Hepati\

tis>Number > of Hepatitis Cases Climbs in Southern West Virginia> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Innogenetics_say\

s_US>Innogenetics > says US court confirms Abbott infringed Hepatitis C virus

patent> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Treatment_of_Hep\

atitis>Treatment > of Hepatitis C Reduces Incidence of Non-Hodgkin's Lymphoma> *

>

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_The_Good_Times>T\

he > Good Times Roll for Pharmasset> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Philippines_orde\

rs_Novartis>Philippines > orders Novartis to pull anti-arthritis drug> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Sen._Brown_Reque\

sts>Sen. > Brown Requests Probe of FDA's Fast-Track Drug Approvals> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Hemophiliac_Soci\

ety_says>Hemophiliac > Society says tainted blood victims will be inflamed by

dropped charges> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Plan_in_works>Pl\

an > in works to cover uninsured> > For the Team at HCSP> > CD Mazoff, PhD>

Managing Editor, Webmaster> HCV Advocate> www.hcvadvocate.org> HBV Advocate>

www.hbvadvocate.org

_________________________________________________________________

Connect and share in new ways with Windows Live.

http://www.windowslive.com/share.html?ocid=TXT_TAGHM_Wave2_sharelife_012008

[Guest guest]

HCV ADVOCATE WEEKLY NEWS REVIEW:> A Review of HCV, HBV and HIV/HCV Coinfection

Related News and Highlights> > Week Ending: January 19th, 2008> > Alan

Franciscus> Editor-in-Chief> > To download pdf version click >

<http://www.hcvadvocate.org/news/NewsUpdates_pdf/News_Review_2008/NewsRev-240.pd\

f>here> > This Issue:> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Healthcare_Help_\

for>Healthcare > Help for the Burmese> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Britain's_transp\

lant_crisis:>Britain's > transplant crisis: Poor lifestyle fuels big rise in

waiting lists> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_SF_med_center>SF

> med center to use gene therapy> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Studies_from_Uni\

versity>Studies > from University of California in the area of cancer vaccines

published> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Court_Declines_E\

xperimental>Court > Declines Experimental Drugs Case> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Schering-Plough_\

Reports_Top-Line>Schering-Plough > Reports Top-Line Results of the Ideal Study>

* >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Roche_Responds_t\

o>Roche > Responds to Announcement of " IDEAL " Hepatitis C Trial Results> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Drug_Approved._I\

s>Drug > Approved. Is Disease Real?> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Study_Probes_Why\

>Study > Probes Why U.S. Blacks Wary of Medical Trials> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Three_Rivers_Pha\

rmaceuticals®,>Three > Rivers Pharmaceuticals®, LLC Acquires Hepatitis C

Drug Infergen® > from Valeant Pharmaceuticals> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_New_York_outpati\

ent>New > York outpatient oversight among toughest> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Proteomic_profil\

ing_shown>Proteomic > profiling shown more accurate than traditional biomarkers

in > identifying liver cancer> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Basic_accord_end\

s>Basic > accord ends hepatitis C legal fights> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Lessening_the_Bu\

rden>Lessening > the Burden of Hepatitis B Virus Infection and Liver Cancer

Among > Asian and Pacific Islander Americans> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_GB_Virus_C>GB >

Virus C May Reduce Severity of HCV-Related Liver Disease in HIV Patients> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Ribosomal_S-6_Ki\

nase>Ribosomal > S-6 Kinase Mediates Development of Liver Fibrosis> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Living_Donor_Liv\

er>Living > Donor Liver Transplant Yields Better Survival Than Deceased Donor> *

>

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Percutaneous_Rad\

iofrequency_Ablatio>Percutaneous > Radiofrequency Ablation Effective for Small

Liver Tumors> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Acute_inflammato\

ry_demyelinating>Acute > inflammatory demyelinating polyneuropathy associated

with pegylated > interferon alpha 2a therapy for chronic hepatitis C virus

infection> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Dept._of_Health:\

>Dept. > of Health: Manhasset doc reused syringes> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Hepatitis_C_Case\

s>Hepatitis > C Cases Alarm Bosnian Doctors> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Outpatient_clini\

c_had>Outpatient > clinic had its own hepatitis outbreak> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Attention:_Extra\

-hepatic_manifestat>Attention: > Extra-hepatic manifestation of hepatitis C

virus infection> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Vertex_Shares_Ri\

se>Vertex > Shares Rise After Upgrade> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_What_is_the>What

> is the more suitable for early detection of low abundant >

lamivudine-resistant mutants?> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Liver-gender_dis\

ruption_makes>Liver-gender > disruption makes men more vulnerable to liver

cancer> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Number_of_Hepati\

tis>Number > of Hepatitis Cases Climbs in Southern West Virginia> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Innogenetics_say\

s_US>Innogenetics > says US court confirms Abbott infringed Hepatitis C virus

patent> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Treatment_of_Hep\

atitis>Treatment > of Hepatitis C Reduces Incidence of Non-Hodgkin's Lymphoma> *

>

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_The_Good_Times>T\

he > Good Times Roll for Pharmasset> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Philippines_orde\

rs_Novartis>Philippines > orders Novartis to pull anti-arthritis drug> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Sen._Brown_Reque\

sts>Sen. > Brown Requests Probe of FDA's Fast-Track Drug Approvals> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Hemophiliac_Soci\

ety_says>Hemophiliac > Society says tainted blood victims will be inflamed by

dropped charges> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Plan_in_works>Pl\

an > in works to cover uninsured> > For the Team at HCSP> > CD Mazoff, PhD>

Managing Editor, Webmaster> HCV Advocate> www.hcvadvocate.org> HBV Advocate>

www.hbvadvocate.org

_________________________________________________________________

Connect and share in new ways with Windows Live.

http://www.windowslive.com/share.html?ocid=TXT_TAGHM_Wave2_sharelife_012008

[Guest guest]

HCV ADVOCATE WEEKLY NEWS REVIEW:> A Review of HCV, HBV and HIV/HCV Coinfection

Related News and Highlights> > Week Ending: January 19th, 2008> > Alan

Franciscus> Editor-in-Chief> > To download pdf version click >

<http://www.hcvadvocate.org/news/NewsUpdates_pdf/News_Review_2008/NewsRev-240.pd\

f>here> > This Issue:> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Healthcare_Help_\

for>Healthcare > Help for the Burmese> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Britain's_transp\

lant_crisis:>Britain's > transplant crisis: Poor lifestyle fuels big rise in

waiting lists> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_SF_med_center>SF

> med center to use gene therapy> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Studies_from_Uni\

versity>Studies > from University of California in the area of cancer vaccines

published> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Court_Declines_E\

xperimental>Court > Declines Experimental Drugs Case> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Schering-Plough_\

Reports_Top-Line>Schering-Plough > Reports Top-Line Results of the Ideal Study>

* >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Roche_Responds_t\

o>Roche > Responds to Announcement of " IDEAL " Hepatitis C Trial Results> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Drug_Approved._I\

s>Drug > Approved. Is Disease Real?> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Study_Probes_Why\

>Study > Probes Why U.S. Blacks Wary of Medical Trials> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Three_Rivers_Pha\

rmaceuticals®,>Three > Rivers Pharmaceuticals®, LLC Acquires Hepatitis C

Drug Infergen® > from Valeant Pharmaceuticals> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_New_York_outpati\

ent>New > York outpatient oversight among toughest> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Proteomic_profil\

ing_shown>Proteomic > profiling shown more accurate than traditional biomarkers

in > identifying liver cancer> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Basic_accord_end\

s>Basic > accord ends hepatitis C legal fights> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Lessening_the_Bu\

rden>Lessening > the Burden of Hepatitis B Virus Infection and Liver Cancer

Among > Asian and Pacific Islander Americans> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_GB_Virus_C>GB >

Virus C May Reduce Severity of HCV-Related Liver Disease in HIV Patients> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Ribosomal_S-6_Ki\

nase>Ribosomal > S-6 Kinase Mediates Development of Liver Fibrosis> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Living_Donor_Liv\

er>Living > Donor Liver Transplant Yields Better Survival Than Deceased Donor> *

>

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Percutaneous_Rad\

iofrequency_Ablatio>Percutaneous > Radiofrequency Ablation Effective for Small

Liver Tumors> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Acute_inflammato\

ry_demyelinating>Acute > inflammatory demyelinating polyneuropathy associated

with pegylated > interferon alpha 2a therapy for chronic hepatitis C virus

infection> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Dept._of_Health:\

>Dept. > of Health: Manhasset doc reused syringes> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Hepatitis_C_Case\

s>Hepatitis > C Cases Alarm Bosnian Doctors> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Outpatient_clini\

c_had>Outpatient > clinic had its own hepatitis outbreak> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Attention:_Extra\

-hepatic_manifestat>Attention: > Extra-hepatic manifestation of hepatitis C

virus infection> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Vertex_Shares_Ri\

se>Vertex > Shares Rise After Upgrade> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_What_is_the>What

> is the more suitable for early detection of low abundant >

lamivudine-resistant mutants?> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Liver-gender_dis\

ruption_makes>Liver-gender > disruption makes men more vulnerable to liver

cancer> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Number_of_Hepati\

tis>Number > of Hepatitis Cases Climbs in Southern West Virginia> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Innogenetics_say\

s_US>Innogenetics > says US court confirms Abbott infringed Hepatitis C virus

patent> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Treatment_of_Hep\

atitis>Treatment > of Hepatitis C Reduces Incidence of Non-Hodgkin's Lymphoma> *

>

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_The_Good_Times>T\

he > Good Times Roll for Pharmasset> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Philippines_orde\

rs_Novartis>Philippines > orders Novartis to pull anti-arthritis drug> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Sen._Brown_Reque\

sts>Sen. > Brown Requests Probe of FDA's Fast-Track Drug Approvals> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Hemophiliac_Soci\

ety_says>Hemophiliac > Society says tainted blood victims will be inflamed by

dropped charges> * >

<http://www.hcvadvocate.org/news/newsRev/2008/NewsRev-240.html#_Plan_in_works>Pl\

an > in works to cover uninsured> > For the Team at HCSP> > CD Mazoff, PhD>

Managing Editor, Webmaster> HCV Advocate> www.hcvadvocate.org> HBV Advocate>

www.hbvadvocate.org

_________________________________________________________________

Connect and share in new ways with Windows Live.

http://www.windowslive.com/share.html?ocid=TXT_TAGHM_Wave2_sharelife_012008